0000899243-19-002710.txt : 20190205
0000899243-19-002710.hdr.sgml : 20190205
20190205195320
ACCESSION NUMBER: 0000899243-19-002710
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190201
FILED AS OF DATE: 20190205
DATE AS OF CHANGE: 20190205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shepard Jay
CENTRAL INDEX KEY: 0001587788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36361
FILM NUMBER: 19569561
MAIL ADDRESS:
STREET 1: 15977 GRANDVIEW AVENUE
CITY: MONTE SERENO
STATE: CA
ZIP: 95030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aravive, Inc.
CENTRAL INDEX KEY: 0001513818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264106690
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LYONDELLBASELL TOWER
STREET 2: 1221 MCKINNEY STREET, SUITE 3200
CITY: HOUSTON
STATE: TX
ZIP: 77010
BUSINESS PHONE: 936-355-1910
MAIL ADDRESS:
STREET 1: LYONDELLBASELL TOWER
STREET 2: 1221 MCKINNEY STREET, SUITE 3200
CITY: HOUSTON
STATE: TX
ZIP: 77010
FORMER COMPANY:
FORMER CONFORMED NAME: Versartis, Inc.
DATE OF NAME CHANGE: 20110223
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-01
0
0001513818
Aravive, Inc.
ARAV
0001587788
Shepard Jay
C/O ARAVIVE, INC., LYONDELLBASSELL TOWER
1221 MCKINNEY ST.
HOUSTON
TX
77010
1
1
0
0
President and CEO
Common Stock
2019-02-01
4
S
0
204
4.14
D
83909
D
Common Stock
2019-02-01
4
S
0
969
4.14
D
82940
D
Common Stock
2019-02-01
4
S
0
990
4.14
D
81950
D
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units, which were previously reported in Table I following the date of grant.
/s/ Kevin Haas, Attorney-in-fact
2019-02-05